Atara Biotherapeutics, Inc. (ATRA)

4.19 -0.01 (-0.24%) USD  |  NASDAQ  |  Feb 24, 14:11
More

Atara Biotherapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ATRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
Pfizer Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
AbbVie, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade